Affimed(AFMD)

8.16 %

今开:8.14昨收:8.15
最高:8.17最低:7.94
涨停价:跌停价:
总市值:970657133

Affimed的热门评论

BioNews | AACR 2021回顾,Affimed表现亮眼

蹊之美股生物医药04-19 22:00

作者:林出 微信公众号:蹊之美股生物医药 / CaesarBiotech 标的公司:Affimed(NASDAQ:AFMD);iTeosTherapeutics(NASDAQ:ITOS);EliLilly(NYSE:LLY);OncternalTherapeutics(NASDAQ:ONCT);Sanofi(NASDAQ:SNY); Bristol-MyersSquibb(NYSE:BMY) AACR 2021(美国癌症研究协会年会)落幕,Affimed(A...

Affimed的最新评论

Affimed的公告

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-192099 Act: 34 Size: 29 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-167904 Act: 34 Size: 131 KB 网页链接

$Affimed(AFMD)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-21-000373 Act: 34 Size: 107 KB 网页链接

$Affimed(AFMD)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-21-053202 Act: 34 Size: 77 KB 网页链接

$Affimed(AFMD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001047469-21-000956 Act: 34 Size: 8 MB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-117084 Act: 34 Size: 170 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-116238 Act: 34 Size: 2 MB 网页链接

$Affimed(AFMD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-050088 Act: 34 Size: 94 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-110851 Act: 34 Size: 42 KB 网页链接

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-075455 Act: 34 Size: 33 KB 网页链接